Lifecore Biomedical, Inc. (LFCR) Balance Sheet
LFCR balance sheet, FY2026
May 31, 2026 · U.S. dollars$232.2M assets = $246.4M liabilities + −$14.2M equity
Liabilities exceed assets: shareholders’ equity is negative (−$14.2M).
Both columns are drawn to the same scale: what LFCR owns equals what it owes plus shareholders’ equity. Hover a block for its value.
LFCR financial health
Descriptive bands, not a rating. Fiscal FY2026.
LFCR balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $358.0MFY2017 | $232.2MFY2026 | −4.7%/yr | |
| Total liabilities | $129.9MFY2017 | $246.4MFY2026 | +7.4%/yr | |
| Shareholders’ equity | $226.6MFY2017 | −$14.2MFY2026 | — | |
| Cash & short-term investments | $5.4MFY2017 | $17.5MFY2026 | +13.9%/yr | |
| Total debt | $54.0MFY2017 | $142.6MFY2026 | +11.4%/yr | |
| Net cash (debt) | −$48.6MFY2017 | −$125.1MFY2026 | −$76.6M | |
| Working capital | $29.8MFY2017 | $58.7MFY2026 | +$28.9M | |
| Book value per share | $8.20FY2017 | −$0.38FY2026 | — | |
| Current ratio | 1.58FY2017 | 3.49FY2026 | +1.91 | |
| Debt / equity | 0.24FY2017 | 97.92FY2025 | +97.68 | |
| Shares outstanding | 27.7MFY2017 | 37.4MFY2026 | +3.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
LFCR assets
LFCR liabilities and equity
LFCR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
LFCR balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $17.5M | $8.3M | $8.5M | $991,000 | $1.6M | $1.2M | $360,000 | $1.1M | $2.9M | $5.4M |
| Cash & equivalents | $17.5M | $8.3M | $8.5M | $991,000 | $1.6M | $1.2M | $360,000 | $1.1M | $2.9M | $5.4M |
| Receivables | $33.8M | $43.7M | $31.2M | $38.3M | $48.2M | $41.4M | $76.2M | $69.6M | $53.9M | $45.9M |
| Inventory | $29.1M | $32.3M | $40.0M | $36.0M | $66.8M | $63.1M | $66.3M | $54.1M | $31.8M | $25.3M |
| Other current assets | $1.9M | $1.5M | $1.4M | $41.4M | $7.1M | $42.7M | $14.2M | $8.3M | $8.5M | $4.7M |
| Total current assets | $82.3M | $85.7M | $81.0M | $116.7M | $123.7M | $148.3M | $157.1M | $133.0M | $97.1M | $81.3M |
| Property, plant & equipment (net) | $127.3M | $129.0M | $149.2M | $124.2M | $139.0M | $137.4M | $217.7M | $200.0M | $159.6M | $133.2M |
| Goodwill & intangible assets | $18.1M | $18.1M | $18.1M | $18.1M | $29.4M | $59.5M | $107.5M | $122.0M | $76.4M | $77.6M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $45.1M | $56.9M | $61.1M | $0 | $0 |
| Other non-current assets | $4.5M | $6.6M | $5.7M | $15.7M | $3.0M | $112.6M | $2.2M | $2.9M | $71.7M | $65.9M |
| Total assets | $232.2M | $239.3M | $254.0M | $274.7M | $295.2M | $502.9M | $541.3M | $519.1M | $404.7M | $358.0M |
| Liabilities | ||||||||||
| Accounts payable | $5.8M | $8.2M | $16.3M | $13.0M | $15.8M | $16.3M | $51.6M | $54.0M | $34.7M | $24.5M |
| Short-term debt | $1.3M | $3.8M | $4.9M | $142.5M | $45.6M | $30.6M | $93.4M | $61.9M | $31.9M | $7.9M |
| Deferred revenue | $8.7M | $3.4M | $2.1M | $919,000 | $919,000 | $637,000 | $352,000 | $499,000 | $2.6M | $310,000 |
| Total current liabilities | $23.6M | $30.2M | $38.9M | $176.6M | $79.2M | $101.9M | $164.4M | $137.1M | $88.4M | $51.5M |
| Long-term debt | $135.6M | $127.0M | $120.5M | $101.3M | $97.6M | $164.9M | $101.4M | $87.2M | $0 | $0 |
| Lease obligations | $6.2M | $387,000 | $9.1M | $11.0M | $15.0M | $27.5M | $30.8M | $3.5M | — | — |
| Other long-term liabilities | $87.2M | $80.8M | $83.3M | $0 | $10.4M | $33.4M | $44.5M | $24.7M | $63.8M | $78.4M |
| Total liabilities | $246.4M | $238.0M | $242.6M | $186.9M | $187.2M | $300.1M | $310.3M | $248.9M | $152.1M | $129.9M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $37,000 | $37,000 | $31,000 | $30,000 | $30,000 | $29,000 | $29,000 | $29,000 | $28,000 | $27,000 |
| Retained earnings (deficit) | −$223.2M | −$205.2M | −$166.5M | −$79.0M | −$58.9M | $38.6M | $71.2M | $109.7M | $109.3M | $84.5M |
| Accumulated other comprehensive income | — | — | −$42.6M | −$586,000 | −$586,000 | −$1.4M | −$2.8M | $64,000 | $1.1M | $432,000 |
| Total shareholders' equity | −$14.2M | $1.3M | $11.3M | $87.8M | $107.9M | $202.8M | $231.0M | $270.1M | $252.6M | $226.6M |
| Key figures | ||||||||||
| Total debt | $142.6M | $130.8M | $133.6M | $247.8M | $153.2M | $215.9M | $221.1M | $152.5M | $72.9M | $54.0M |
| Net cash (debt) | −$125.1M | −$122.6M | −$125.1M | −$246.8M | −$151.5M | −$214.7M | −$220.8M | −$151.4M | −$70.0M | −$48.6M |
| Working capital | $58.7M | $55.5M | $42.2M | −$59.9M | $44.5M | $46.4M | −$7.3M | −$4.0M | $8.7M | $29.8M |
| Tangible book value | −$32.3M | −$16.7M | −$6.8M | $69.7M | $78.5M | $143.2M | $123.6M | $148.2M | $176.2M | $149.0M |
| Book value per share | −$0.38 | $0.04 | $0.31 | $2.98 | $3.66 | $6.92 | $7.92 | $9.44 | $9.05 | $8.20 |
| Shares outstanding | 37.4M | 34.8M | 36.7M | 29.5M | 29.5M | 29.3M | 29.2M | 28.6M | 27.9M | 27.7M |
| Current ratio | 3.49 | 2.84 | 2.08 | 0.66 | 1.56 | 1.46 | 0.96 | 0.97 | 1.10 | 1.58 |
| Quick ratio | 2.18 | 1.72 | 1.02 | 0.22 | 0.63 | 0.42 | 0.47 | 0.52 | 0.64 | 1.00 |
| Debt / equity | — | 97.92 | 11.81 | 2.82 | 1.42 | 1.06 | 0.96 | 0.56 | 0.29 | 0.24 |
| Equity / assets | −6.1% | 0.6% | 4.5% | 32.0% | 36.6% | 40.3% | 42.7% | 52.0% | 62.4% | 63.3% |
| May '26 | Feb '26 | Aug '25 | May '25 | Feb '25 | Nov '24 | Aug '24 | May '24 | Feb '24 | Nov '23 | Aug '23 | May '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $17.2M | $20.8M | $18.9M | $8.3M | $5.4M | $9.5M | $5.5M | $8.5M | $19.1M | $3.2M | $8.6M | $3.0M |
| Cash & equivalents | $17.2M | $20.8M | $18.9M | $8.3M | $5.4M | $9.5M | $5.5M | $8.5M | $19.1M | $3.2M | $8.6M | $3.0M |
| Receivables | $30.5M | $26.9M | $29.1M | $43.7M | $19.4M | $20.2M | $25.1M | $31.2M | $29.0M | $30.2M | $26.6M | $32.4M |
| Inventory | $25.5M | $28.2M | $33.8M | $32.3M | $34.6M | $39.2M | $41.6M | $40.0M | $40.8M | $41.4M | $41.7M | $48.7M |
| Other current assets | $10.5M | $1.8M | $2.1M | $1.5M | $24.8M | $13.0M | $1.9M | $1.4M | $4.9M | $1.8M | $5.9M | $4.4M |
| Total current assets | $83.7M | $77.6M | $83.9M | $85.7M | $84.2M | $81.9M | $74.2M | $81.0M | $93.9M | $76.7M | $82.8M | $88.4M |
| Property, plant & equipment (net) | $123.7M | $125.5M | $123.6M | $129.0M | $130.5M | $152.9M | $151.1M | $149.2M | $138.7M | $146.9M | $140.4M | $126.7M |
| Goodwill & intangible assets | $13.9M | $18.1M | $18.1M | $18.1M | $18.1M | $18.1M | $18.1M | $18.1M | $18.1M | $18.1M | $18.1M | $18.3M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $8.2M | $4.3M | $9.6M | $6.6M | $4.9M | $2.6M | $3.4M | $5.7M | $2.9M | $4.1M | $4.3M | $2.7M |
| Total assets | $229.5M | $225.5M | $235.2M | $239.3M | $237.7M | $255.4M | $246.8M | $254.0M | $253.5M | $245.8M | $245.6M | $236.2M |
| Liabilities | ||||||||||||
| Accounts payable | $7.5M | $6.6M | $10.1M | $8.2M | $7.4M | $15.0M | $18.0M | $16.3M | $22.1M | $19.0M | $15.7M | $14.8M |
| Short-term debt | $970,000 | $1.3M | $1.3M | $3.8M | $4.9M | $4.9M | $4.9M | $4.9M | $1.9M | — | — | $1.5M |
| Deferred revenue | $5.3M | $5.9M | — | $3.4M | $2.6M | $937,000 | $654,000 | $2.1M | $4.1M | — | — | $2.7M |
| Total current liabilities | $21.6M | $20.5M | $30.0M | $30.2M | $31.1M | $35.3M | $40.5M | $38.9M | $39.3M | $40.3M | $35.4M | $37.7M |
| Long-term debt | $148.5M | $142.1M | $135.0M | $127.0M | $124.0M | $119.0M | $127.2M | $120.5M | $116.2M | $109.0M | $107.1M | $99.0M |
| Lease obligations | $5.8M | $5.8M | — | $387,000 | $5.4M | $11.5M | $8.9M | $9.1M | $9.2M | $10.5M | $10.7M | $11.0M |
| Other long-term liabilities | $43.3M | $42.1M | $33.5M | $80.8M | $35.1M | $41.3M | $83.1M | $83.3M | $102.2M | $95.2M | $116.6M | $65.3M |
| Total liabilities | $213.4M | $204.7M | $198.4M | $238.0M | $235.5M | $239.9M | $250.8M | $242.6M | $257.8M | $244.4M | $259.2M | $201.9M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $38,000 | $37,000 | $37,000 | $37,000 | $37,000 | $37,000 | $31,000 | $31,000 | $30,000 | — | — | $30,000 |
| Retained earnings (deficit) | −$244.3M | −$238.2M | −$218.1M | −$205.2M | −$204.1M | −$191.5M | −$182.8M | −$166.5M | −$178.5M | −$175.1M | −$189.3M | −$140.1M |
| Accumulated other comprehensive income | — | — | — | — | — | — | −$43.4M | −$42.6M | −$39.2M | — | — | −$39.2M |
| Total shareholders' equity | $16.1M | $20.8M | $36.8M | $1.3M | $2.2M | $15.4M | −$3.9M | $11.3M | −$4.2M | $1.4M | −$13.6M | $34.2M |
| Key figures | ||||||||||||
| Total debt | $155.1M | $150.1M | $137.5M | $130.8M | $130.3M | $131.3M | $136.9M | $133.6M | $112.6M | $109.0M | $107.1M | $126.9M |
| Net cash (debt) | −$137.8M | −$129.3M | −$118.7M | −$122.6M | −$124.9M | −$121.9M | −$131.3M | −$125.1M | −$93.5M | −$105.7M | −$98.5M | −$124.0M |
| Working capital | $62.0M | $57.1M | $54.0M | $55.5M | $53.1M | $46.6M | $33.7M | $42.2M | $54.6M | $36.5M | $47.4M | $50.8M |
| Tangible book value | $2.2M | $2.7M | $18.7M | −$16.7M | −$15.9M | −$2.6M | −$22.0M | −$6.8M | −$22.3M | −$16.7M | −$31.6M | $15.9M |
| Book value per share | $0.43 | $0.55 | $0.98 | $0.04 | $0.06 | $0.45 | −$0.13 | $0.37 | −$0.14 | $0.05 | −$0.45 | $1.13 |
| Shares outstanding | 37.6M | 37.5M | 37.4M | 37.0M | 37.0M | 34.4M | 30.9M | 30.6M | 30.3M | 30.5M | 30.5M | 30.3M |
| Current ratio | 3.87 | 3.79 | 2.80 | 2.84 | 2.71 | 2.32 | 1.83 | 2.08 | 2.39 | 1.91 | 2.34 | 2.35 |
| Quick ratio | 2.20 | 2.33 | 1.60 | 1.72 | 0.80 | 0.84 | 0.76 | 1.02 | 1.22 | 0.83 | 1.00 | 0.94 |
| Debt / equity | 9.64 | 7.23 | 3.74 | 97.92 | 58.48 | 8.50 | — | 11.81 | — | 76.68 | — | 3.71 |
| Equity / assets | 7.0% | 9.2% | 15.6% | 0.6% | 0.9% | 6.0% | −1.6% | 4.5% | −1.7% | 0.6% | −5.5% | 14.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 16, 2026); data from EODHD.
LFCR financial position
At the end of fiscal 2026 (May 31, 2026), Lifecore Biomedical had total assets of $232.2 million (down 3.0% from a year earlier), total liabilities of $246.4 million and shareholders' equity of -$14.2 million. It held $17.5 million in cash and short-term investments against $142.6 million of debt, net debt of $125.1 million. Its current ratio was 3.49.
Related: LFCR income statement, LFCR cash flow statement, LFCR key metrics. See the LFCR stock overview for the latest quote and news.
LFCR balance sheet FAQ
What are Lifecore Biomedical's total assets?
Lifecore Biomedical reported total assets of $232.2 million at the end of fiscal 2026 (May 31, 2026), compared with $239.3 million a year earlier.
How much debt does Lifecore Biomedical have?
Lifecore Biomedical had $142.6 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Lifecore Biomedical have?
Lifecore Biomedical held $17.5 million in cash and short-term investments at the end of fiscal 2026; with $142.6 million of debt that is net debt of $125.1 million.
What is Lifecore Biomedical's book value?
Lifecore Biomedical's shareholders' equity (book value) was -$14.2 million at the end of fiscal 2026, or −$0.38 per share.
What is Lifecore Biomedical's current ratio?
Lifecore Biomedical had current assets of $82.3 million and current liabilities of $23.6 million, a current ratio of 3.49 (it can cover its short-term obligations).
How much goodwill does Lifecore Biomedical have?
Lifecore Biomedical carried $18.1 million of goodwill and intangible assets, 7.8% of total assets, at the end of fiscal 2026.